NCT05514080

A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

A Pilot Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 Diabetes

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: McGill University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to generate preliminary data in an inpatient setting to help optimize an insulin dosing logic (that decides how much to deliver insulin) for Eli Lilly's system.

Detailed description

After being informed about the study and potential risks, all participants giving written informed consent will undergo an admission visit to determine eligibility for study entry. Participants who meet the inclusion and exclusion criteria will then participate in two 41-hour intervention visits using Eli Lilly's insulin dosing algorithm.

Conditions

• Diabetes Mellitus, Type 2

Interventions

Type	Name	Description
OTHER	Insulin closed-loop	41-hour intervention period in which the participants are treated with rapid insulin in the closed-loop system.

Timeline

• Start date: 2019-12-06
• Primary completion: 2021-09-04
• Completion: 2022-03-30
• First posted: 2022-08-24
• Last updated: 2022-08-24

Locations

1 site across 1 country: Canada